Arkolith/Insider Trading/SGMO/Form 4

Macrae Sandy

PRESIDENT, CEO AND DIRECTOR, DirectorSANGAMO THERAPEUTICS, INC (SGMO) · full profile →Form 4 · filed Feb 26, 2025
No Open-Market Flow
Open-Market Buys
$0
Open-Market Sells
$0
Net Open-Market Flow
$0
Transactions
4
3 non-derivative · 1 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Feb 25, 2025Tax withholding(F)11K$0.96$10K2.1M
Feb 25, 2025Grant(A)375K—$02.5M
Feb 24, 2025Tax withholding(F)7K$1.00$7K2.1M

Derivative Transactions (Table II)

DateActionSharesPriceValueOwned After
Feb 25, 2025Grant(A)1.8M—$01.8M

Transaction Codes

F
Shares withheld for taxes
A
Grant / award

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0001415889-25-005704) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML